Cefmenoxime

From Wikipedia, the free encyclopedia

Cefmenoxime
Systematic (IUPAC) name
(6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-
2-methoxyimino-acetyl]amino}-3-[(1-methyltetrazol-
5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]
oct-2-ene-2-carboxylic acid
Identifiers
CAS number 65085-01-0
ATC code J01DD05
PubChem 5361486
DrugBank APRD00851
Chemical data
Formula C16H17N9O5S3 
Mol. mass 511.562 g/mol
Pharmacokinetic data
Bioavailability 100% (given IM)
Protein binding 50% to 70%
Metabolism Negligible
Half life 1 hour
Excretion Renal, unchanged
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Intramuscular, intravenous

Cefmenoxime is a third-generation cephalosporin antibiotic.

[edit] External links

  • DDB 30892
  • Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Deguchi K, Oda S, Tanaka S, Nakane Y, Fukumoto T (1995). "Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis". Jpn J Antibiot 48 (5): 602–9. PMID 7637194. 
  • Paladino J, Fell R (1994). "Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia.". Ann Pharmacother 28 (3): 384–9. PMID 8193431. 
  • Duncker G, Reich U, Krausse R (1994). "Cefmenoxime in corneal organ culture.". Ophthalmologica 208 (5): 262–6. PMID 7816419. 


Languages